Literature DB >> 30830519

PBC: Better Solutions to Beat Feeling Beat.

Naw April Phaw1, David E J Jones2.   

Abstract

Mesh：

Year:  2019        PMID： 30830519     DOI： 10.1007/s10620-019-05552-3

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

1.  Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosis.

Authors:  A Jacoby; A Rannard; D Buck; N Bhala; J L Newton; O F W James; D E J Jones
Journal:  Gut       Date:  2005-06-16       Impact factor: 23.059

2.  Autonomic dysfunction in primary biliary cirrhosis correlates with fatigue severity.

Authors:  Julia L Newton; Adrian Davidson; Simon Kerr; Nij Bhala; Jessie Pairman; Jennifer Burt; David E J Jones
Journal:  Eur J Gastroenterol Hepatol       Date:  2007-02       Impact factor: 2.566

3.  Fatigue in primary biliary cirrhosis.

Authors:  Matilda Hale; Julia L Newton; David E J Jones
Journal:  BMJ       Date:  2012-10-22

4.  Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence.

Authors:  Julia L Newton; G John Gibson; Mark Tomlinson; Katharine Wilton; David Jones
Journal:  Hepatology       Date:  2006-07       Impact factor: 17.425

5.  Treatment of Fatigue in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

Authors:  Jennifer Y Lee; Christopher J Danford; Hirsh D Trivedi; Elliot B Tapper; Vilas R Patwardhan; Alan Bonder
Journal:  Dig Dis Sci       Date:  2019-01-10       Impact factor: 3.199

6.  Fatigue in primary biliary cirrhosis.

Authors:  K Cauch-Dudek; S Abbey; D E Stewart; E J Heathcote
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

7.  Pilot study of peripheral muscle function in primary biliary cirrhosis: potential implications for fatigue pathogenesis.

Authors:  Kieren G Hollingsworth; Julia L Newton; Roy Taylor; Claire McDonald; Jeremy M Palmer; Andrew M Blamire; David E J Jones
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-08       Impact factor: 11.382

8.  A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis.

Authors:  Frederik Nevens; Pietro Andreone; Giuseppe Mazzella; Simone I Strasser; Christopher Bowlus; Pietro Invernizzi; Joost P H Drenth; Paul J Pockros; Jaroslaw Regula; Ulrich Beuers; Michael Trauner; David E Jones; Annarosa Floreani; Simon Hohenester; Velimir Luketic; Mitchell Shiffman; Karel J van Erpecum; Victor Vargas; Catherine Vincent; Gideon M Hirschfield; Hemant Shah; Bettina Hansen; Keith D Lindor; Hanns-Ulrich Marschall; Kris V Kowdley; Roya Hooshmand-Rad; Tonya Marmon; Shawn Sheeron; Richard Pencek; Leigh MacConell; Mark Pruzanski; David Shapiro
Journal:  N Engl J Med       Date:  2016-08-18       Impact factor: 91.245

9.  The inter-relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitis.

Authors:  J K Dyson; N Wilkinson; L Jopson; G Mells; A Bathgate; M A Heneghan; J Neuberger; G M Hirschfield; S J Ducker; R Sandford; G Alexander; D Stocken; D E J Jones
Journal:  Aliment Pharmacol Ther       Date:  2016-09-19       Impact factor: 8.171

10.  The impact of liver transplantation on the phenotype of primary biliary cirrhosis patients in the UK-PBC cohort.

Authors:  Greta Pells; George F Mells; Marco Carbone; Julia L Newton; Andrew J Bathgate; Andrew K Burroughs; Michael A Heneghan; James M Neuberger; Darren B Day; Samantha J Ducker; Richard N Sandford; Graeme J Alexander; David E J Jones
Journal:  J Hepatol       Date:  2013-03-04       Impact factor: 25.083
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.